Compare Align Technology, Inc. (ALGN) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Toronto-Dominion Bank — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Toronto-Dominion Bank trades at $120.25 (market cap $198.82B). The key difference: Toronto-Dominion Bank is far larger — about 15.5× Align Technology, Inc.'s market cap, and Toronto-Dominion Bank pays a 2.69% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | TD | |
|---|---|---|
Market Cap | $12.86B | $198.82B |
Sector | Health | Financials |
52-Week High | $207.19 | $122.25 |
52-Week Low | $124.88 | $72.55 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
TD stock trades at $120.53, up 0.65% with a bullish technical signal and strong analyst consensus. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS expected at $1.71. Revenue grew to $61.28B in 2025 with a robust 23.38% net income margin, though cash flow from operations was negative. The stock trades at a P/E of 20.08 and P/B of 2.51, with a consensus price target of $153.00 representing 27% upside potential.
TD presents a compelling investment case with strong profitability metrics, consistent earnings beats, and positive analyst sentiment. Key risks include volatile operating cash flows, rising debt-to-asset ratios, and economic sensitivity. The current valuation appears reasonable relative to growth prospects, supported by institutional confidence and dividend stability. Upside potential exists if the company maintains its earnings momentum and executes on operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
